CCK-8 induces NGF and BDNF synthesis and modulates TrkA and TrkB expression in the rat hippocampus and septum: Effects on kindling development
Authors:
- Paola TirassaPTPaola Tirassa
- Nicola CostaNCNicola Costa
- 1 January 2007
- journal article
- Published by Elsevier in Neurochemistry International
- Vol. 50 (1) , 130-138
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Neuroprotection associated with running: is it a result of increased endogenous neurotrophic factors?Neuroscience, 2003
- Hippocampal brain‐derived neurotrophic factor gene regulation by exercise and the medial septumJournal of Neuroscience Research, 2002
- Nerve Growth Factor in Neurological and Non-Neurological Diseases: Basic Findings and Emerging Pharmacological ProspectivesCurrent Pharmaceutical Design, 2001
- Administration of Cholecystokinin Sulphated Octapeptide (CCK-8S) Induces Changes on Rat Amino Acid Tissue Levels and on a Behavioral Test for AnxietyGeneral Pharmacology: The Vascular System, 1998
- CCK in Anxiety and Cognitive ProcessesNeuroscience & Biobehavioral Reviews, 1998
- Knock-Out Mice Reveal a Critical Antiepileptic Role for Neuropeptide YJournal of Neuroscience, 1997
- Cholinergic regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) but not neurotrophin-3 (NT-3) mRNA levels in the developing rat hippocampusJournal of Neuroscience, 1993
- Function and evolution in the NGF family and its receptorsJournal of Neuroscience Research, 1992
- Systematic administration of a cholecystokinin analogue, ceruletide, protects against ischemia-induced neurodegeneration in gerbilsEuropean Journal of Pharmacology, 1992
- Chronic treatment with scopolamine and physostigmine changes nerve growth factor (NGF) receptor density and NGF content in rat brainBrain Research, 1991